Definitive Contract HDTRA107C0005

Award Date 10/6/06
Potential Completion Date 10/5/10
Potential Value $25M
Ultimate Awardee
Not listed
NAICS Category
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
130
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $30,704,925.57 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Achaogen, Inc., a for-profit organization. The contract was awarded on September 1, 2008, with a period of performance through August 27, 2016, and was not set aside for any specific business type. The contract was awarded under a Broad Agency Announcement (BAA) solicitation, BAA...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Sanofi Pasteur Vaxdesign Corp, a for-profit foreign-owned organization. The contract is a Cost Plus Fixed Fee Definitive Contract with a ceiling value of $10,779,939.95 and an ultimate completion date of March 24, 2018. The contract was awarded on March 21, 2013 and does not have a set-aside designation. The contract is for the BASE YEAR, indicating it may be part of a larger contract...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Nanobiosym Inc., a for-profit woman-owned small business. The contract, valued at $2,050,000.00, is for a base period with no set-aside designation. The contract type is a definitive contract with cost-no-fee pricing. The place of performance is East Cambridge, Massachusetts. Nanobiosym Inc. has been awarded federal contracts and grants in the past. Without additional details on the original...
This is a $9,941,163.00 delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to Applied Research Associates, Inc. (ARA), a for-profit subchapter S corporation. The contract provides program management, operations, and explosives support services. It has an ultimate completion date of August 18, 2027. The contract has a cost-plus-fixed-fee pricing structure and is not set aside. As the prime contractor, ARA has subcontracted with three firms to provide personnel,...
This is a $18,981,194.00 cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to Applied Research Associates, Inc. (ARA) for Chemical-Biological Threat Test Support. The contract has an ultimate completion date of June 19, 2028. This award is part of a larger $4 billion Indefinite Delivery/Indefinite Quantity (IDIQ) contract that ARA holds with DTRA for Combating Weapons of Mass Destruction support. The contract is not set-aside. ARA has subcontracted...
This is a federal contract award from the Defense Threat Reduction Agency (DTRA), a defense agency, to Dublin City University, a non-profit organization located in Ireland. The contract, which does not have a set-aside designation, is a definitive contract with a cost-no-fee pricing type. The contract was awarded on April 2, 2007 with a ceiling value of $3,715,224.19 and an ultimate completion date of April 1, 2011. The contract is for the "BASE YEAR" of performance. Without additional...
This is a federal contract award to Applied Research Associates, Inc. (ARA) by the Defense Threat Reduction Agency (DTRA) with a ceiling value of $386,246.00. The contract is for Task Area 2 - Field Test Support, and is a delivery order under a larger contract vehicle. The contract has no set-aside designation. ARA is the prime contractor and has provided services such as threat detection technologies, munitions effectiveness analysis, counter-intelligence, infrastructure research, and...
The Defense Threat Reduction Agency awarded PTC Therapeutics, Inc., doing business as PTC, a $18,613,510.19 cost-plus-fixed-fee definitive contract on September 22, 2006 to support the agency's programs. The contract has a completion date of September 21, 2009 and calls for work to be performed in South Plainfield, New Jersey. As a definitive contract issued by DTRA, this vehicle likely funds research, development, testing, and evaluation efforts aimed at countering weapons of mass destruction...
This is a federal contract award to Applied Research Associates, Inc. (ARA), a globally recognized research and engineering company, by the Defense Threat Reduction Agency (DTRA), a defense agency. The contract has a value of $8,792,126.28 and is a Cost Plus Fixed Fee Delivery Order for TEST OPERATION TECHNOLOGY AND services. The contract has a period of performance through May 11, 2018. ARA has been awarded multiple indefinite delivery/indefinite quantity (IDIQ) contracts from various federal...
This is a Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Chesapeake Perl, Inc. for an "ALTERNATIVE MANUFACTURING PROCESS FOR BIOSCAVENGER R & D EFFORT". The contract has a ceiling value of $3,183,760.00 and a period of performance through September 20, 2016. The contract was awarded on September 21, 2012 and does not have a set-aside designation. Based on the agency and description, this contract is likely related to...

This is a definitive contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Achaogen, Inc., a for-profit organization, for the preclinical development of novel therapeutics that attenuate virulence of, and inhibit resistance in, Class A bacterial pathogens. The contract has a ceiling value of $24,610,645.00 and was awarded on October 6, 2006, with an ultimate completion date of October 5, 2010. The contract is a cost no fee arrangement and does not have a set-aside designation. The award suggests Achaogen, Inc. is developing specialized countermeasures to address biological threats as part of DTRA's mission to reduce the threat of weapons of mass destruction.

Generated 11/23/24, 10:01 AM